Gross total but not incomplete resection of glioblastoma prolongs survival in the era of radiochemotherapy†

Extent of resection in patients with glioblastoma: limiting factors, perception of resectability, and effect on survival

(2012) Daniel Orringer et al.   JOURNAL OF NEUROSURGERY

The Risk of Getting Worse: Surgically Acquired Deficits, Perioperative Complications, and Functional Outcomes After Primary Resection of Glioblastoma

(2012) Sasha Gulati et al.   World Neurosurgery

An extent of resection threshold for newly diagnosed glioblastomas

(2011) Nader Sanai et al.   JOURNAL OF NEUROSURGERY

Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial

(2011) Christian Senft et al.   LANCET ONCOLOGY

Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review

(2011) Pieter L Kubben et al.   LANCET ONCOLOGY

Postoperative Deterioration in Health Related Quality of Life as Predictor for Survival in Patients with Glioblastoma: A Prospective Study

(2011) Asgeir S. Jakola et al.   PLoS One

Predominant influence of MGMT methylation in non-resectable glioblastoma after radiotherapy plus temozolomide

(2010) N. Thon et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Counterbalancing risks and gains from extended resections in malignant glioma surgery: a supplemental analysis from the randomized 5-aminolevulinic acid glioma resection study

(2010) Walter Stummer et al.   JOURNAL OF NEUROSURGERY

Intraobserver and Interobserver Agreement in Volumetric Assessment of Glioblastoma Multiforme Resection

(2010) Pieter L Kubben et al.   NEUROSURGERY

Prognostic Significance of Molecular Markers and Extent of Resection in Primary Glioblastoma Patients

(2009) J. Felsberg et al.   CLINICAL CANCER RESEARCH

EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME

(2009) et al.   NEUROSURGERY

Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3

(2007) Thierry Gorlia et al.   LANCET ONCOLOGY